Fujian Haixi Pharmaceuticals Co., Ltd.
Fujian Haixi Pharmaceuticals Co., Ltd. (HKSE: 2637) is trading at HK$172.00, about ₹2,104 at today's HKD/INR rate, as of 25 Sep 2026, 3:18 AM ET. Indian residents can buy Fujian Haixi Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$172.00
Today's high
HK$172.00
52 week low
HK$124.00
52 week high
HK$302.40
2637 opened at HK$172.00, closed previously at HK$172.00, and has traded between HK$124.00 and HK$302.40 over the past 52 weeks.
About
Fujian Haixi Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical products in China. The company offers drugs for oncology, ophthalmology, respiratory, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It also provides pharmaceuticals technical services. In addition, the company offers generic alternatives, such as Anbili, a generic of mosapride citrate tablets; Haihuitong 5mg/10mg and 5mg/20mg, a generic of amlodipine besilate and atorvastatin calcium tablets; Ruiantuo, a generic of cinacalcet hydrochloride tablets; and Saixifu, a generic of hydroxychloroquine sulfate tablets. Further, it provides Haibiping, a generic of valsartan and amlodipine tablets; Anyoufan, a generic of escitalopram oxalate tablets; Haikexi, a generic of valsartan tablets; Anfeiping, a generic of diclofenac sodium enteric-coated tablets; and Jishuning, a generic of cetirizine hydrochloride oral solution. Additionally, the company's pipeline includes C019199, a drug candidate targeting the modulation of the immunosuppressive tumor microenvironment for the treatment of advanced osteosarcoma, which has completed phase II clinical trials; HXP056, an oral small-molecule drug designed to treat retinopathy-related diseases, which has completed phase I clinical trial; HXP089, an oral small-molecule drug targeting glioblastoma multiforme; and HXP090, an oral small-molecule drug designed specifically targeting idiopathic pulmonary fibrosis. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. Fujian Haixi Pharmaceuticals Co., Ltd. was incorporated in 2012 and is based in Fuzhou, China.
Key statistics
Avg. volume
151.85K
Market cap
HK$13.54B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.80
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Fujian Haixi Pharmaceuticals from India
Indian residents can buy Fujian Haixi Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Fujian Haixi Pharmaceuticals and place an order
Find Fujian Haixi Pharmaceuticals by name or by its ticker, 2637, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Fujian Haixi Pharmaceuticals trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Fujian Haixi Pharmaceuticals position in HKD and INR. Fujian Haixi Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Fujian Haixi Pharmaceuticals from India
Trading and taxes when buying Fujian Haixi Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneFujian Haixi Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Fujian Haixi Pharmaceuticals stock?
Yes. Fujian Haixi Pharmaceuticals (2637) has been listed on the Hong Kong Stock Exchange since 2025, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Fujian Haixi Pharmaceuticals share cost in rupees?
One Fujian Haixi Pharmaceuticals share is HK$172.00 — about ₹2,104 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Fujian Haixi Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Fujian Haixi Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Fujian Haixi Pharmaceuticals?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Fujian Haixi Pharmaceuticals shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Fujian Haixi Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Fujian Haixi Pharmaceuticals pay a dividend?
No. Fujian Haixi Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Fujian Haixi Pharmaceuticals from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Fujian Haixi Pharmaceuticals a Hong Kong SAR China company, and does that change how it is taxed?
Fujian Haixi Pharmaceuticals trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Fujian Haixi Pharmaceuticals trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Fujian Haixi Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Fujian Haixi Pharmaceuticals holding, its cost and its closing value.
How do I sell Fujian Haixi Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.